Fieldpoint Private Securities’s Takeda Pharmaceutical TAK Stock Holding History

Fieldpoint Private Securities’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$4K	Sell	260 -1,687	-87%	-$24.1K	﹤0.01%	1003
2022 Q1	$28K	Buy	1,947 +260	+15%	+$3.82K	0.01%	752
2021 Q4	$23K	Buy	1,687 +1,310	+347%	+$18.4K	﹤0.01%	837
2021 Q3	$6K	Hold	377	–	–	﹤0.01%	1228
2021 Q2	$6K	Sell	377 -95	-20%	-$1.62K	﹤0.01%	1176
2021 Q1	$9K	Sell	472 -1,277	-73%	-$23K	﹤0.01%	1040
2020 Q4	$32K	Buy	+1,749	New	+$30.7K	0.01%	569

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fieldpoint Private Securities's TAK Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Takeda Pharmaceutical (TAK) stake by 87% in Q2 2022, selling an estimated $24.1K and leaving 260 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1003.

Fieldpoint Private Securities first reported a position in TAK in Q4 2020 and has held it in 7 quarters since. The position peaked at $32K in Q4 2020. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

Fieldpoint Private Securities held 260 shares of Takeda Pharmaceutical worth $4K as of Q2 2022.
Fieldpoint Private Securities sold 1,687 Takeda Pharmaceutical shares in Q2 2022, an estimated $24.1K.
Takeda Pharmaceutical made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1003 holding.
Fieldpoint Private Securities first reported a position in Takeda Pharmaceutical in Q4 2020 and has held it in 7 quarters since.
Fieldpoint Private Securities's Takeda Pharmaceutical position peaked at $32K in Q4 2020.
283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.